Issued Patents All Time
Showing 25 most recent of 30 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12195525 | Tau immunotherapy | Philip James Dolan, III, Yue Liu, Robin Barbour | 2025-01-14 |
| 11643457 | Tau immunotherapy | Philip James Dolan, III, Yue Liu, Robin Barbour | 2023-05-09 |
| 11492393 | Tau immunotherapy | Philip James Dolan, III, Yue Liu, Robin Barbour | 2022-11-08 |
| 10752679 | Tau immunotherapy | Philip James Dolan, III, Yue Liu, Robin Barbour | 2020-08-25 |
| 10501531 | Tau immunotherapy | Philip James Dolan, III, Yue Liu, Robin Barbour | 2019-12-10 |
| 8791243 | Treatment and prophylaxis of amyloidosis | Dale B. Schenk, Jonathan S. Wall, Jose Saldanha | 2014-07-29 |
| 8636981 | Detection of amyloid deposits using anti-amyloid antibodies | Dale B. Schenk, Jonathan S. Wall | 2014-01-28 |
| 8404815 | Chimeric, humanized, or human antibody 2A4 | Dale B. Schenk | 2013-03-26 |
| 8357781 | Neuroactive fragments of APP | Kelly Johnson-Wood, Thierry Bussiere | 2013-01-22 |
| 8268973 | Anti-amyloid antibodies | Dale B. Schenk, Jose Saldanha | 2012-09-18 |
| 7993627 | Methods for determining whether a compound alters the amount of at least one αβ (X-41) peptide and the amount of either total αβ or at least one αβ (X-40) peptide produced by a non-human mammal | Martin Citron, Dennis J. Selkoe, Dale B. Schenk | 2011-08-09 |
| 7928203 | Chimeric, humanized, or human antibody 2A4 | Dale B. Schenk, Jonathan S. Wall, Jose Saldanha | 2011-04-19 |
| 7811769 | Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau | Carmen Vigo-Pelfrey, Dale B. Schenk, Robin Barbour | 2010-10-12 |
| 7700309 | Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (X->41) and tau | Carmen Vigo-Pelfrey, Dale B. Shenk, Robin Barbour | 2010-04-20 |
| 7427392 | Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau | Carmen Vigo-Pelfrey, Dale B. Schenk, Robin Barbour | 2008-09-23 |
| 7186881 | Testing compounds for effects on synaptophysin in transgenic mice expressing an Alzheimer's disease FAD DNA sequence | Kate Dora Games, Dale B. Schenk, Lisa McConlogue, Russell E. Rydel | 2007-03-06 |
| 6717031 | Method for selecting a transgenic mouse model of alzheimer's disease | Kate Dora Games, Dale B. Schenk, Lisa McConlogue, Russell E. Rydel | 2004-04-06 |
| 6610493 | Screening compounds for the ability to alter the production of amyloid-&bgr; peptide | Martin Citron, Dennis J. Selkoe, Dale B. Schenk | 2003-08-26 |
| 6284221 | Method for identifying .beta.-amyloid peptide production inhibitors | Dale B. Schenk, Michael Schlossmacher, Dennis J. Selkoe, Carmen Vigo-Pelfrey | 2001-09-04 |
| 6114133 | Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-.beta. peptide (x-.gtoreq.41) | Carmen Vigo-Pelfrey, Dale B. Schenk, Robin Barbour | 2000-09-05 |
| 6018024 | Methods and compositions for monitoring cellular processing of beta-amyloid precursor protein | Dale B. Schenk, Lawrence C. Fritz | 2000-01-25 |
| 5837672 | Methods and compositions for the detection of soluble .beta.-amyloid peptide | Dale B. Schenk, Michael Schlossmacher, Dennis J. Selkoe, Carmen Vigo-Pelfrey | 1998-11-17 |
| 5721130 | Antibodies and fragments thereof which bind the carboxyl-terminus of an amino-terminal fragment of .beta.APP | Dale B. Schenk, Lawrence C. Fritz | 1998-02-24 |
| 5605811 | Methods and compositions for monitoring cellular processing of beta-amyloid precursor protein | Dale B. Schenk, Lawrence C. Fritz | 1997-02-25 |
| 5604102 | Methods of screening for .beta.-amyloid peptide production inhibitors | Lisa McConlogue, Dale B. Schenk, Sukanto Sinha, Jun Zhao | 1997-02-18 |